Genetic and chemical induction of systemic TSLP released from skin keratinocytes leads primarily to the activation of Th2 cells that specifically target breast cancer cells, block breast cancer promotion, and revert high-grade tumors into low-grade, fibrocystic structures in the absence of any inflammation, affecting the normal breast glands in close proximity to the tumor foci. This evidence concerns the gene TSLP and breast carcinoma.